CYT
Vanguard Group’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-687,391
| Closed | -$2.09M | – | 4506 |
|
|
2023
Q4 | $2.09M | Buy |
687,391
+46,611
| +7% | +$142K | ﹤0.01% | 3587 |
|
|
2023
Q3 | $1.82M | Buy |
640,780
+55,997
| +10% | +$159K | ﹤0.01% | 3618 |
|
|
2023
Q2 | $1.52M | Hold |
584,783
| – | – | ﹤0.01% | 3756 |
|
|
2023
Q1 | $1.06M | Hold |
584,783
| – | – | ﹤0.01% | 3894 |
|
|
2022
Q4 | $965K | Buy |
584,783
+291
| +0% | +$480 | ﹤0.01% | 3927 |
|
|
2022
Q3 | $1.12M | Sell |
584,492
-27,106
| -4% | -$52K | ﹤0.01% | 3967 |
|
|
2022
Q2 | $1.83M | Buy |
611,598
+226,645
| +59% | +$678K | ﹤0.01% | 3840 |
|
|
2022
Q1 | $1.45M | Buy |
384,953
+41,720
| +12% | +$157K | ﹤0.01% | 4084 |
|
|
2021
Q4 | $3.9M | Buy |
343,233
+1,982
| +0.6% | +$22.5K | ﹤0.01% | 3746 |
|
|
2021
Q3 | $5.99M | Buy |
341,251
+271,251
| +388% | +$4.76M | ﹤0.01% | 3535 |
|
|
2021
Q2 | $1.5M | Buy |
+70,000
| New | +$1.5M | ﹤0.01% | 4049 |
|